OQROGet OQRO Pro
Insider trade

Onkure Therapeutics (OKUR)CFO sold ~$722

Jason A. Leverone, CFO at Onkure Therapeutics, sold ~$722 of Onkure Therapeutics shares.

~$722
Approx. value · 303 sh @ $2.38
13K
Holds after · shares reported
Traded
Jun 23, 2025
Filed
Jun 25, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 12, 2025Insider10% owner sold ~$48K of OKUR shares in the open market
  2. May 15, 2025Insider · 2 peopleInsiders: 2 purchases (~$2.6M), 1 sale (~$3.4M)
  3. Jun 23, 2025 · this disclosureInsiderCFO sold ~$722 of OKUR shares in the open market

What came next

  1. Jun 23, 2025InsiderCEO sold ~$210 of OKUR shares in the open market
  2. Sep 22, 2025Insider · 2 peopleInsiders: 2 sales (~$1K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Onkure Therapeutics

For Onkure Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OKUR page.

Other recent filings by Jason A. Leverone, Chief Financial Officer

The full history of Jason A. Leverone, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Onkure Therapeutics

Everything OQRO holds on this company is on its OKUR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data